VivoSim Labs, Inc. Line of Credit Facility, Maximum Borrowing Capacity
VivoSim Labs, Inc. (VIVS) had Line of Credit Facility, Maximum Borrowing Capacity of $400.00 thousand as of 2025-09-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2026-08-12
- 2025-09-30: Line of Credit Facility, Maximum Borrowing Capacity $400.00K.
- 2024-09-30: Line of Credit Facility, Maximum Borrowing Capacity $400.00K.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2025-09-30 | $400.00K 10-Q · filed 2026-08-12 |
| 2024-09-30 | $400.00K 10-K · filed 2025-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |